NAUT News and Press, Nautilus Biotechnology Inc. From 05/03/22

Nautilus Biotechnology, Inc. (NAUT) Q1 2022 Earnings Conference Call May 3, 2022 8:30 a.m. ET Company Participants Sujal Patel - Co-Founder & CEO Anna Mowry - CFO Parag Mallick - Co-Founder & Chief Scientific Officer Conference Call Participants Matt Kim - Jefferies Stephanie Yan - Co...

Nautilus Biotechnology press release (NASDAQ:NAUT): Q1 Non-GAAP EPS of -$0.13 beats by $0.03. Cash, cash equivalents, and investments were $349.0 million as of March 31, 2022. For further details see: Nautilus Biotechnology Non-GAAP EPS of -$0.13 beats by $0.03

SEATTLE, May 03, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis, today reported financial results for the first quarter ended March 31, 2022. Recent Highlights S...

Nautilus Biotechnology (NASDAQ:NAUT) is scheduled to announce Q1 earnings results on Tuesday, May 3rd, before market open. The consensus EPS Estimate is -$0.16 and the consensus Revenue Estimate is $0.17M Over the last 3 months, EPS estimates have seen 1 upward revision and 1 downward. For ...

ACRE,AGCO,AHH,AME,AQUA,ARNC,ATKR,BEN,BIIB,OTCQX:BNPQF,BP,BPMC,BR,BRSP,CEIX,CMI,CMS,CNHI,CNP,CTLT,CVLT,CZOO,DD,DEA,DK,DKL,OTCPK:DPSTF,DSKE,EL,ESPR,ETN,ETRN,EXPD,FIS,OTCQB:FNMA,GEO,GLDD,HLT,HSIC,HWM,INCY,IPGP,IT,ITT,ITW,J,KKR,KOPN,LDOS,LEA,LGIH,LODE,LPX,MLM,MPC,MPLX,MTOR,NAUT,OTCQX:NHYDY,NNN,NR...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re gearing up for another busy day of trading with a breakdown of the biggest pre-market stock movers for Thursday! Source: f11photo/Shutterstock.com Moving stocks this morning is drug trial news, recent e...

SEATTLE, April 12, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the appointments of Gwen Weld as Chief People Officer and Sher...

SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial results for the first quarter 20...

• Co-founder and Chief Scientist Parag Mallick, Ph.D., to present lecture at Annual Congress of the European Proteomics Association (EuPA) • Associate Director Greg Kapp, Ph.D., to present poster at American Association for Cancer Research (AACR) Annual Meeting S...

SEATTLE, March 31, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the appointment of Karen Akinsanya, Ph.D., to its Board of Dir...